Cargando…

Cardiovascular Involvement in Sjögren’s Syndrome

Sjögren Syndrome (SS) seems to be associated with a greater “overall risk” of cardiovascular (CV) and cerebrovascular events. Although not conventionally considered a feature of the disease, CV events represent a major burden in SS patients. CV risk is the consequence of a complex combination of mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atzeni, Fabiola, Gozza, Francesco, Cafaro, Giacomo, Perricone, Carlo, Bartoloni, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134348/ https://www.ncbi.nlm.nih.gov/pubmed/35634284 http://dx.doi.org/10.3389/fimmu.2022.879516

Ejemplares similares

Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome
por: Cafaro, Giacomo, et al.
Publicado: (2021)

Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter?
por: Bartoloni, Elena, et al.
Publicado: (2019)

Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren’s Syndrome
por: Bianconi, Vanessa, et al.
Publicado: (2023)

COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
por: Perricone, Carlo, et al.
Publicado: (2020)

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
por: Perricone, Carlo, et al.
Publicado: (2020)

Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
por: Perricone, Carlo, et al.
Publicado: (2021)

Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future
por: Bursi, Roberto, et al.
Publicado: (2021)

Cardiovascular Disease in Primary Sjögren’s Syndrome: Raising Clinicians’ Awareness
por: Casian, Mihnea, et al.
Publicado: (2022)

Biomarkers and Diagnostic Testing for Renal Disease in Sjogren's Syndrome
por: Ramponi, Giacomo, et al.
Publicado: (2020)

Insulin-Like Growth Factor Binding Protein 6 in Rheumatoid Arthritis: A Possible Novel Chemotactic Factor?
por: Alunno, Alessia, et al.
Publicado: (2017)

Neuro-Sjögren: Peripheral Neuropathy With Limb Weakness in Sjögren's Syndrome
por: Seeliger, Tabea, et al.
Publicado: (2019)

A Glimpse Into the Microbiome of Sjögren’s Syndrome
por: Deng, Chuiwen, et al.
Publicado: (2022)

Liver Fibrosis in Primary Sjögren’s Syndrome
por: Androutsakos, Theodoros, et al.
Publicado: (2022)

The role of virus infections in Sjögren’s syndrome
por: Maslinska, Maria, et al.
Publicado: (2022)

Hospitalizations for infections in primary Sjögren’s syndrome patients: a nationwide incidence study : Severe infections in Sjögren’s syndrome
por: Goulabchand, Radjiv, et al.
Publicado: (2022)

The Diagnostic Performance of Early Sjögren’s Syndrome Autoantibodies in Juvenile Sjögren’s Syndrome: The University of Florida Pediatric Cohort Study
por: Thatayatikom, Akaluck, et al.
Publicado: (2021)

Emerging of a new CD3(+)CD31(H)CD184(+) tang cell phenothype in Sjögren’s syndrome induced by microencapsulated human umbilical cord matrix-derived multipotent stromal cells
por: Montanucci, Pia, et al.
Publicado: (2023)

Comorbidities in the UK Primary Sjögren’s Syndrome Registry
por: Tarn, Jessica, et al.
Publicado: (2022)

Interferons in Sjögren’s Syndrome: Genes, Mechanisms, and Effects
por: Li, He, et al.
Publicado: (2013)

Recent Advances in Mouse Models of Sjögren's Syndrome
por: Gao, Yunzhen, et al.
Publicado: (2020)

Recent Advances in the Use of Exosomes in Sjögren’s Syndrome
por: Huang, Yupeng, et al.
Publicado: (2020)

Pathogenesis and treatment of Sjogren’s syndrome: Review and update
por: Zhan, Qipeng, et al.
Publicado: (2023)

The Impact of SARS-CoV-2 Outbreak on Primary Sjögren's Syndrome: An Italian Experience
por: Carubbi, Francesco, et al.
Publicado: (2020)

Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren’s Syndrome
por: Chen, Jiali, et al.
Publicado: (2021)

Abnormal Changes of Monocyte Subsets in Patients With Sjögren’s Syndrome
por: He, Yan, et al.
Publicado: (2022)

TLR7 Signaling Drives the Development of Sjögren’s Syndrome
por: Wang, Yawen, et al.
Publicado: (2021)

Autonomic Nervous System Dysfunction in Primary Sjögren’s Syndrome
por: Davies, Kristen, et al.
Publicado: (2021)

The Multiple Roles of B Cells in the Pathogenesis of Sjögren’s Syndrome
por: Du, Wenhan, et al.
Publicado: (2021)

CD8(+) T Lymphocytes: Crucial Players in Sjögren’s Syndrome
por: Zhou, Huimin, et al.
Publicado: (2021)

Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study
por: Bartoloni, Elena, et al.
Publicado: (2021)

Correlation Between Salivary Microbiome of Parotid Glands and Clinical Features in Primary Sjögren’s Syndrome and Non-Sjögren’s Sicca Subjects
por: Kim, Donghyun, et al.
Publicado: (2022)

Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development
por: Goules, Andreas V., et al.
Publicado: (2020)

Composition and regulation of the immune microenvironment of salivary gland in Sjögren’s syndrome
por: Tan, Zhen, et al.
Publicado: (2022)

Exposure to particulate pollutant increases the risk of hospitalizations for Sjögren’s syndrome
por: Zhang, Tian-Ping, et al.
Publicado: (2022)

Exploiting the role of T cells in the pathogenesis of Sjögren’s syndrome for therapeutic treatment
por: An, Qi, et al.
Publicado: (2022)

Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets
por: Bodewes, Iris L. A., et al.
Publicado: (2019)

Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art
por: Talotta, Rossella, et al.
Publicado: (2019)

Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19
por: Perricone, Carlo, et al.
Publicado: (2020)

T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives
por: Alunno, Alessia, et al.
Publicado: (2015)

Current Insights in Microbiome Shifts in Sjogren’s Syndrome and Possible Therapeutic Interventions
por: Tsigalou, Christina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ne0vspa4919ct6pmoqmo11a7at